Clinicalusedefinition-interaction-example

FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example ClinicalUseDefinition/example-interaction (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.

Generated Narrative: ClinicalUseDefinition example-interaction

StructureDefinition Work Group: brr

type: interaction

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/example/MPID#{mpid}; classification = B01AF02

interaction
interactant
item: alphaconazole
interactant
item: betaconazole
type: Inhibitor
Effects

- Concept

* Increased plasma concentration
management: Careful monitoring of dose

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.